Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 309

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

New treatment of acute hypoxemic respiratory failure: Noninvasive pressure support ventilation delivered by helmet—A pilot controlled trial

Antonelli, Massimo, Conti, Giorgio, Pelosi, Paolo, Gregoretti, Cesare, Pennisi, Mariano Alberto, Costa, Roberta, Severgnini, Paolo, Chiaranda, Maurizio, Proietti, Rodolfo · 2002 · Critical Care Medicine

Abstract

OBJECTIVE: To assess the efficacy of noninvasive pressure support ventilation (NPSV) using a new special helmet as first-line intervention to treat patients with hypoxemic acute respiratory failure (ARF), in comparison to NPSV using standard facial mask. DESIGN AND SETTING: Prospective clinical pilot investigation with matched control group in three intensive care units of university hospitals. PATIENTS AND METHODS: Thirty-three consecutive patients without chronic obstructive pulmonary disease and with hypoxemic ARF (defined as severe dyspnea at rest, respiratory rate >30 breaths/min, PaO2:FiO2 < 200, and active contraction of the accessory muscles of respiration) were enrolled. Each patient treated with NPSV by helmet was matched with two controls with ARF treated with NPSV via a facial mask, selected by simplified acute physiologic score II, age, PaO2/FiO2, and arterial pH at admission. Primary end points were the improvement of gas exchanges, the need for endotracheal intubation, and the complications related to NPSV. RESULTS: The 33 patients and the 66 controls had similar characteristics at baseline. Both groups improved oxygenation after NPSV. Eight patients (24%) in the helmet group and 21 patients (32%) in the facial mask group (p = .3) failed NPSV and were intubated. No patients failed NPSV because of intolerance of the technique in the helmet group in comparison with 8 patients (38%) in the mask group (p = .047). Complications related to the technique (skin necrosis, gastric distension, and eye irritation) were fewer in the helmet group compared with the mask group (no patients vs. 14 patients (21%), p = .002). The helmet allowed the continuous application of NPSV for a longer period of time (p = .05). Length of stay in the intensive care unit, intensive care, and hospital mortality were not different. CONCLUSIONS: NPSV by helmet successfully treated hypoxemic ARF, with better tolerance and fewer complications than facial mask NPSV.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/00003246-200203000-00019

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Cited by

See all 309

Metadata

Authors
Antonelli, M., Conti, G., Pelosi, P., Gregoretti, C., Pennisi, M. A., Costa, R., Severgnini, P., Chiaranda, M., & Proietti, R.
Venue
Critical Care Medicine
Published
2002-03
Volume
30
Issue
3
Pages
602-608
ISSN
0090-3493 (ISSN-L)
OpenAlex
W2033867602
Cited by
309
References
19
FWCI
12.78
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: New treatment of acute hypoxemic respiratory failure: Noninvasive pressure support ventilation delivered by helmet—A pilot controlled trial. https://app.cochat.ai/papers/10.1097/00003246-200203000-00019
The paper
Antonelli, M., Conti, G., Pelosi, P., Gregoretti, C., Pennisi, M. A., Costa, R., Severgnini, P., Chiaranda, M., & Proietti, R. (2002). New treatment of acute hypoxemic respiratory failure: Noninvasive pressure support ventilation delivered by helmet—A pilot controlled trial. Critical Care Medicine. https://doi.org/10.1097/00003246-200203000-00019

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.